DOI

10.21007/con.dnp.2026.0144

Faculty Advisor

Bobby Bellflower DNSc, NNP-BC, FAAN, FAANP, FNAP

Subject Matter Expert

breast cancer screening standardization

Clinical Site

University of Tennessee Health Science Center

Document Type

Poster

Publication Date

Spring 4-28-2026

Disciplines

Health and Medical Administration | Investigative Techniques | Medicine and Health Sciences | Nursing | Nursing Administration | Quality Improvement

Abstract

Purpose 

To compare U.S. Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) breast cancer screening guidelines for women aged 40–74, and to recommend adopting one consistent, standardized guideline in practice. Standardization can improve care continuity, patient adherence, reduce anxiety, support early detection, and lower mortality.

Background 

Breast cancer is the second leading cause of cancer-related death amongst women. The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. The ACS recommends an annual mammogram. Differences between the two organizations for screening emphasize the need for a common alignment to reduce breast cancer mortality. As breast cancer awareness, treatment, and technology advance, it is essential to provide consistent recommendations for early diagnosis and mortality reduction. Addressing inconsistent screening intervals is essential to improving diagnostic outcomes and reducing mortality.

Method 

A scoping literature review was conducted from August to November 2023 to identify evidence comparing USPSTF and ACS breast cancer screening recommendations. Searches were performed in PubMed, MEDLINE, Embase, CINAHL, Scopus, and the Cochrane Library using relevant keywords. Eleven articles met inclusion criteria and were appraised using The Ohio State University rapid critical appraisal tool. Findings were synthesized using an outcome‑focused synthesis table.

Results 

Most studies we used supported initiating screening at age 40, with evidence favoring more frequent mammography for early detection. However, no statistically significant difference was found between annual and biennial screening outcomes. Across the literature, emphasis on shared decision-making, patient-centered communication, and concerns regarding overdiagnosis and false positives revealed a persistent gap between guideline recommendations and clinical practice.

Implications for Nursing Practice 

Variability in screening guidelines contributes to disparities in early detection. Standardized recommendations improve patient education, support shared decision‑making, and strengthen continuity of care. Nursing leadership remains essential for policy advocacy and implementing screening standards that enhance preventive health outcomes.

 

 

 

 

 

 

 

Share

COinS